This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Logman JF, Heeg BM, Botteman MF, Kaura S, van Hout BA.Economic evaluation of zoledronic acid for the prevention of fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the United Kingdom. 2008 Breast Cancer Symposium: abstr. 177, 5 Sep 2008. Available from: URL: http://www.breastcasymposium.org
Rights and permissions
About this article
Cite this article
Zoledronic acid cost effective in preventing AI-associated bone loss. Pharmacoecon. Outcomes News 564, 1 (2008). https://doi.org/10.2165/00151234-200805640-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805640-00001